Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
6.04
-0.07 (-1.15%)
Jun 11, 2026, 3:04 PM CST

SHE:000919 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,2631,5171,7711,5481,4951,502
Short-Term Investments
289.9393.03165.22337.45250-
Trading Asset Securities
1,213939.31706.05233.8692.351.25
Cash & Short-Term Investments
2,7662,8492,6422,1191,8371,503
Cash Growth
6.35%7.84%24.69%15.33%22.25%14.12%
Accounts Receivable
742.06690.95686.73591.05467.22507.2
Other Receivables
5.6213.798.168.7653.1216.85
Receivables
747.68704.74694.89599.81520.34524.05
Inventory
219.6233.14271.62290.91250.48245.48
Prepaid Expenses
---0.151.16-
Other Current Assets
18.0110.529.379.6323.7916.29
Total Current Assets
3,7523,7983,6183,0202,6332,289
Property, Plant & Equipment
1,4321,4571,5011,5411,3031,297
Long-Term Investments
60.04211.37431.07369.32265.01638.97
Goodwill
44.3744.3762.42148.7227.3318.05
Other Intangible Assets
317.75322.93325.67341.67258.44140.2
Long-Term Deferred Tax Assets
13.1612.6112.4916.6128.5419.62
Long-Term Deferred Charges
116.88120.5583.3413.9418.2617.85
Other Long-Term Assets
280.6240.3154.494210.726.96
Total Assets
6,0166,0076,0895,4934,5444,448
Accounts Payable
543.66554.97595.31546.69454.04479.36
Accrued Expenses
70.06222.28212.46224.73219.95207.27
Short-Term Debt
----1.4815.01
Current Portion of Leases
8.748.744.233.081.531.06
Current Income Taxes Payable
56.3832.3735.5337.9748.3843.09
Current Unearned Revenue
33.8319.5735.617.6522.1426.9
Other Current Liabilities
242.63138.03143.9182.53117.983.25
Total Current Liabilities
955.29975.951,0271,013865.42855.95
Long-Term Debt
150.1150.1150.12---
Long-Term Leases
33.3432.9834.8538.62.290.59
Long-Term Unearned Revenue
0.60.6810.470.630.79
Long-Term Deferred Tax Liabilities
25.1325.0127.2828.7248.9855.77
Total Liabilities
1,1641,1851,2401,080917.32913.1
Common Stock
621.92621.92623.71511.14510.4504
Additional Paid-In Capital
1,0881,0881,098651.74478.34462.06
Retained Earnings
2,0932,0652,0732,0952,0251,958
Treasury Stock
---6.77-26.99-23.62-
Comprehensive Income & Other
2.712.663.093.424.173.29
Total Common Equity
3,8063,7783,7913,2342,9942,928
Minority Interest
1,0461,0441,0571,178632.88606.84
Shareholders' Equity
4,8524,8224,8494,4123,6273,535
Total Liabilities & Equity
6,0166,0076,0895,4934,5444,448
Total Debt
192.17191.82189.2141.675.316.66
Net Cash (Debt)
2,5742,6582,4532,0771,8321,486
Net Cash Growth
6.74%8.34%18.08%13.39%23.26%12.85%
Net Cash Per Share
4.144.274.144.123.642.95
Filing Date Shares Outstanding
621.92621.92623.71629.06488.88510.4
Total Common Shares Outstanding
621.92621.92623.71511.14488.88504
Working Capital
2,7962,8222,5912,0071,7681,433
Book Value Per Share
6.126.076.086.336.125.81
Tangible Book Value
3,4443,4103,4032,7442,7082,769
Tangible Book Value Per Share
5.545.485.465.375.545.50
Buildings
-1,5101,4951,5071,2941,274
Machinery
-1,4981,4161,3491,1141,074
Construction In Progress
-48.1671.7884.237.8428.78